Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 3284 entries
View as:

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

Phase: N/A Priority: Normal
NCT ID: NCT06109779 Org: User:
Start: 12/04/23 End: 09/30/30 Due: 09/30/31

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03490669 Org: User:
Start: 05/21/18 End: 09/23/19 Due: 09/23/20

Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01369810 Org: User:
Start: 07/31/11 End: 09/30/13 Due: 09/30/14

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

Phase: N/A Priority: Normal
NCT ID: NCT00637273 Org: User:
Start: 01/31/08 End: 07/31/09 Due: 07/31/10

Metabolic Syndrome Observation on a Regional Basis

Phase: N/A Priority: Normal
NCT ID: NCT00933010 Org: User:
Start: 10/31/09 End: 10/31/10 Due: 10/31/11

A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01070784 Org: User:
Start: 01/31/10 End: 10/31/11 Due: 10/31/12

Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01152567 Org: User:
Start: 06/30/10 End: 11/30/10 Due: 11/30/11

Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02039180 Org: User:
Start: 02/28/14 End: 03/31/14 Due: 03/31/15

Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg

Phase: N/A Priority: Normal
NCT ID: NCT00242775 Org: User:
Start: 05/31/05 End: 05/31/06 Due: 05/31/07

An Observational Study to Assess the Prevalence of Heart Failure in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT04072523 Org: User:
Start: 12/03/19 End: 03/01/21 Due: 03/01/22

IRESSA™ (Gefitinib) in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00632723 Org: User:
Start: 04/30/01 End: 10/31/05 Due: 10/31/06

Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00940212 Org: User:
Start: 07/31/09 End: 11/30/09 Due: 11/30/10

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00228462 Org: User:
Start: 03/31/05 End: 04/30/06 Due: 04/30/07

Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid

Phase: N/A Priority: Normal
NCT ID: NCT00838877 Org: User:
Start: 01/31/09 End: 10/31/09 Due: 10/31/10

18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)

Phase: N/A Priority: Normal
NCT ID: NCT00666458 Org: User:
Start: 04/30/08 End: 03/31/09 Due: 03/31/10

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01157078 Org: User:
Start: 06/30/10 End: 11/30/11 Due: 11/30/12

A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01754844 Org: User:
Start: 01/31/13 End: 08/31/13 Due: 08/31/14

European Drug Utilization Study

Phase: N/A Priority: Normal
NCT ID: NCT01594996 Org: User:
Start: 04/24/12 End: 03/27/14 Due: 03/27/15

Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)

Phase: N/A Priority: Normal
NCT ID: NCT00163475 Org: User:
Start: 05/31/04 End: 08/31/05 Due: 08/31/06

Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01154621 Org: User:
Start: 06/30/10 End: 07/31/10 Due: 07/31/11

A Study to Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833

Phase: N/A Priority: Normal
NCT ID: NCT04546347 Org: User:
Start: 09/17/20 End: 01/07/21 Due: 01/07/22

Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take Statins

Phase: N/A Priority: Normal
NCT ID: NCT01047176 Org: User:
Start: 12/31/09 End: 12/31/11 Due: 12/31/12

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05450692 Org: User:
Start: 09/15/22 End: 08/22/25 Due: 08/22/26

To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02093351 Org: User:
Start: 09/01/14 End: 04/29/19 Due: 04/29/20

Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients

Phase: N/A Priority: Normal
NCT ID: NCT01152385 Org: User:
Start: 05/31/10 End: 05/31/11 Due: 05/31/12